NSE - Delayed Quote INR
Rossari Biotech Limited (ROSSARI.NS)
699.35
-5.25
(-0.75%)
At close: April 25 at 3:29:59 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
19,680,770
18,251,880
16,513,170
14,751,760
7,074,080
Cost of Revenue
13,804,680
13,040,730
11,784,580
11,135,360
4,650,630
Gross Profit
5,876,090
5,211,150
4,728,590
3,616,400
2,423,450
Operating Expense
3,988,210
3,383,970
3,212,270
2,314,680
1,421,080
Operating Income
1,887,880
1,827,180
1,516,320
1,301,720
1,002,370
Net Non Operating Interest Income Expense
-137,740
-171,330
-197,940
-85,890
12,730
Pretax Income
1,830,480
1,776,150
1,442,190
1,362,750
1,068,380
Tax Provision
469,820
469,260
369,620
385,800
267,920
Net Income Common Stockholders
1,360,660
1,306,890
1,072,570
976,740
802,200
Diluted NI Available to Com Stockholders
1,360,660
1,306,890
1,072,570
976,740
802,200
Basic EPS
24.62
23.67
19.46
17.81
15.56
Diluted EPS
24.58
23.62
19.38
17.70
15.47
Basic Average Shares
55,263.79
55,209.96
55,114.30
54,848.16
51,565.17
Diluted Average Shares
55,353.14
55,326.67
55,355.54
55,174.96
51,870.85
Rent Expense Supplemental
--
67,000
53,220
46,730
36,600
Total Expenses
17,792,890
16,424,700
14,996,850
13,450,040
6,071,710
Net Income from Continuing & Discontinued Operation
1,360,660
1,306,890
1,072,570
976,740
802,200
Normalized Income
1,327,611.32
1,274,176.36
1,065,207.28
968,739.44
781,776.05
Interest Income
--
22,390
25,210
40,670
42,650
Interest Expense
160,130
193,720
223,150
126,560
29,920
Net Interest Income
-137,740
-171,330
-197,940
-85,890
12,730
EBIT
1,990,610
1,969,870
1,665,340
1,489,310
1,098,300
EBITDA
2,639,890
2,573,770
2,294,650
1,969,860
1,326,590
Reconciled Cost of Revenue
13,804,680
13,040,730
11,784,580
11,135,360
4,650,630
Reconciled Depreciation
649,280
603,900
629,310
480,550
228,290
Net Income from Continuing Operation Net Minority Interest
1,360,660
1,306,890
1,072,570
976,740
802,200
Total Unusual Items Excluding Goodwill
44,460
44,460
9,900
11,160
27,260
Total Unusual Items
44,460
44,460
9,900
11,160
27,260
Normalized EBITDA
2,595,430
2,529,310
2,284,750
1,958,700
1,299,330
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
11,411.32
11,746.36
2,537.28
3,159.44
6,836.05
3/31/2021 - 7/23/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TATVA.BO Tatva Chintan Pharma Chem Limited
725.65
-4.70%
LXCHEM.BO Laxmi Organic Industries Limited
184.65
+0.54%
AARTISURF.NS Aarti Surfactants Limited
445.35
-3.09%
OAL.NS Oriental Aromatics Limited
329.45
+0.34%
VEEDOL.NS Veedol Corporation Limited
1,485.00
-3.37%
VINYLINDIA.NS Vinyl Chemicals (India) Limited
283.75
-5.15%
KIRIINDUS.BO Kiri Industries Limited
599.95
-0.88%
ANURAS.NS Anupam Rasayan India Ltd
856.30
+0.92%
CHEMCON.NS Chemcon Speciality Chemicals Limited
200.51
-3.67%
PRIVISCL.NS Privi Speciality Chemicals Limited
1,899.40
-1.35%